Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Primary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis
Interventions
DRUG

NS-018

Experimental

DRUG

Best Available Therapy

Active Comparator

Trial Locations (52)

4401

Soon Chun Hyang Central Medical Center, Seoul

6120

Universitaetsklinikum Halle (Saale), Halle

10990

Hospital Pulau Pinang, Pulau Pinang

15121

AO SS Antonio, Alessandria

Azienda Ospedaliera SS. Antonio, Alessandria

15586

Hospital Raja Perempuan Zainab II, Kota Bharu

18057

Universitätsmedizin Rostock, Rostock

20121

ASST Fatebenefratelli Sacco, Milan

20122

Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan

21565

Gachon University Gil Medical Center, Incheon

25123

ASST Spedali Civili di Brescia, Brescia

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia

30450

Hospital Raja Permaisuri Bainun, Ipoh

34200

Istanbul Medipol University, Bağcılar

35128

Azienda Ospedaliera di Padova, Padua

40002

Srinagarind Hospital, Khon Kaen

52727

Gyeongsang National University Hospital, Jinju

59100

University Malaya Medical Centre, Kuala Lumpur

Namik Kemal University Medicine School, Tekirdağ

61100

Karadeniz Teknik Universitesi Tip Fak,, Trabzon

68000

Hospital Ampang, Ampang

77002

Houston Methodist Hospital, Houston

77030

MD Anderson Cancer Center, Houston

80100

Hospital Sultanah Aminah, Johor Bahru

80131

AO di Rilievo Ntl A Cardarelli, Naples

Azienda Ospedaliera di Rilievo Nazionale, Naples

AO di Rilievo Nazionale, Napoli

86150

Hamatologisch-onkologische Praxis Heinric/Bangerter Ausgsburg GbR, Augsburg

88586

Hospital Queen Elizabeth, Kota Kinabalu

90110

Songklanagarind Hospital, Songkhla

90127

Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo

95123

"AOU Policlinico - San Marco", Catania

01655

University of Massachusetts Chan Medical School, Worcester

07747

Universitaetsklinikum Jena, Jena

00144

Istituto Nazionale Tumori Regina Elena IRCCS, Roma

00161

Azienda Ospedaliera Universitaria Policlinico Umberto I, Roma

AO Uni Policlinico Umberto I, Rome

Unknown

Sunway Medical Centre, Petaling Jaya

Ege Universitesi Tip Fak,, Izmir

85-168

Szpital Uniwersytecki nr 2 im. dr J. Biziela, Bydgoszcz

40-519

Pratia Onkologia Katowice, Katowice

53-413 ,

Dolnośląskie Centrum Onkologii we Wrocławiu, Oddział Hematologiczny, Wroclaw

164 KR

The Catholic University of Korea, Seoul St. Mary's Hospital, Banpo-dong

CHA Bundang Medical Center, CHA University, Seongnam

BA1 3NG

Royal United Hospitals - Bath, Bath

SE1 9RT

Guys Hospital, London

WC1E 6HX

University College London Hospitals, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

PL6 8DH

Derriford Hospital, Plymouth

B71 4HJ

Sandwell & West Birmingham Hospital, West Bromwich

EH2XU 4

Western General Hospital, Edinburgh

EH4 2XU

Western General Hospital, Edinburgh

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Nippon Shinyaku Co., Ltd.

INDUSTRY

lead

NS Pharma, Inc.

INDUSTRY

NCT04854096 - Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis | Biotech Hunter | Biotech Hunter